Doximity Inc (DOCS)

Sector:
INFORMATION TECHNOLOGY
Industry:
SOFTWARE
SIC:
SERVICES-COMPUTER PROGRAMMING SERVICES
CEO:
Jeffrey A. Tangney
Employees:
890
500 THIRD STREET, SAN FRANCISCO, CA 94107
(650) 549-4330

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications.

Data derived from most recent annual or quarterly report
Market Cap 3.799 Billion Shares Outstanding191.31 Million Avg 30-day Volume 2.604 Million
P/E Ratio61.2553 Dividend Yield0.0 EPS0.15
Price to Revenue16.4913 Debt to Equity0.0 EBITDA155.339 Million
Price to Book Value7.1531 Operating Margin29.854999999999997 Enterprise Value6.07 Billion
Current Ratio6.992 EPS Growth-0.243 Quick Ratio6.796
1 Yr BETA 1.6629 52-week High/Low 40.12 / 19.71 Profit Margin26.9222
Operating Cash Flow Growth41.8937 Free Cash Flow to Firm (FCFF) TTM 61.363 Million Free Cash Flow to Equity (FCFE) TTM99.815 Million
Altman Z-Score26.1862

Are you looking for this stock instead?

View SEC Filings from DOCS instead.

View recent insider trading info

Funds Holding DOCS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DOCS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2023-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-28:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-06-06:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-16:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-29:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    JORGENSEN PAUL W. CHIEF REVENUE OFFICER

    • Officer
    320,558 2022-08-15 0

    KLIMAN GILBERT H

    • SEE REMARKS
    449,960 2022-08-02 0

    YANG WATKIN PHOEBE L.

    • Director
    0 2022-08-02 0

    CABRAL TIMOTHY S

    • Director
    4,714 2022-07-27 0

    SPAIN KEVIN

    • Director
    806,246 2022-07-27 0

    BENJAMIN REGINA M.

    • Director
    4,714 2022-07-27 0

    WAMPLER KIRA SCHERER

    • Director
    4,714 2022-07-27 0

    KLEINE JOSEPH B. CHIEF COMMERCIAL OFFICER

    • Officer
    924,530 2021-08-18 0

    BRYSON ANNA CHIEF FINANCIAL OFFICER

    • Officer
    75,247 2021-08-13 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Weiss Strategic Interval Fund- Weiss Strategic Interval Fund DOCS -1217.0 shares, $-36777.74 2022-09-30 N-PORT
    Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund DOCS -1401.0 shares, $-51486.75 2023-04-30 N-PORT
    Alger Funds II- Alger Dynamic Opportunities Fund DOCS -13660.0 shares, $-502005.0 2023-04-30 N-PORT
    NORTHERN LIGHTS FUND TRUST II- Invenomic Fund DOCS -276840.0 shares, $-10173870.0 2023-04-30 N-PORT
    RBB Fund, Inc.- Boston Partners Long/Short Research Fund DOCS -33539.0 shares, $-1028641.13 2023-05-31 N-PORT
    RBB Fund, Inc.- Boston Partners Global Long/Short Fund DOCS -11366.0 shares, $-348595.22 2023-05-31 N-PORT
    Trust for Professional Managers- Convergence Long/Short Equity ETF DOCS -1987.0 shares, $-60941.29 2023-05-31 N-PORT
    AGF Investments Trust- AGF U.S. Market Neutral Anti-Beta Fund DOCS -40288.0 shares, $-1370597.76 2023-06-30 N-PORT
    AQR Funds- AQR Alternative Risk Premia Fund DOCS -2208.0 shares, $-75116.16 2023-06-30 N-PORT
    TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund DOCS -4952.0 shares, $-168467.04 2023-06-30 N-PORT
    Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund DOCS -3682.0 shares, $-131557.86 2023-07-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments